DO
CORT icon

denkapparat Operations’s Corcept Therapeutics CORT Stock Holding History

denkapparat Operations’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$205K Buy
+2,360
New +$143K 0.07% 375
2025
Q2 		– Sell
-5,068
Closed -$579K – 252
2025
Q1 		$579K Sell
5,068
-928
-15% -$56.5K 0.61% 51
2024
Q4 		$302K Buy
+5,996
New +$314K 0.45% 92

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

denkapparat Operations's CORT Position: Q2 2026 in Review

denkapparat Operations opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 2,360 shares worth $205K. The stake represents 0.07% of the portfolio and ranks #375 among its holdings. This is a return to the name: denkapparat Operations previously reported a position in CORT as recently as Q1 2025.

denkapparat Operations first reported a position in CORT in Q4 2024 and has held it in 3 quarters since. The position peaked at $579K in Q1 2025. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • denkapparat Operations held 2,360 shares of Corcept Therapeutics worth $205K as of Q2 2026.
  • Corcept Therapeutics was a new denkapparat Operations position in Q2 2026.
  • Corcept Therapeutics made up 0.07% of denkapparat Operations's portfolio in Q2 2026, its #375 holding.
  • denkapparat Operations first reported a position in Corcept Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • denkapparat Operations's Corcept Therapeutics position peaked at $579K in Q1 2025.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on denkapparat Operations's 13F filing for Q2 2026, filed 6 Aug 2026.